BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-4.07%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$8.61B
AUM Growth
+$8.61B
(-11%)
Cap. Flow
-$378M
Cap. Flow
% of AUM
-4.39%
Top 10 Holdings %
Top 10 Hldgs %
30.78%
Holding
207
New
16
Increased
51
Reduced
80
Closed
30
Top Buys
| 1 |
Outset Medical
OM
|
$66.1M |
| 2 |
Boston Scientific
BSX
|
$42.1M |
| 3 |
CareDx
CDNA
|
$31.2M |
| 4 |
Pacific Biosciences
PACB
|
$30.3M |
| 5 |
Aurinia Pharmaceuticals
AUPH
|
$29.8M |
Top Sells
| 1 |
Biogen
BIIB
|
$106M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$81.3M |
| 3 |
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
|
$75.3M |
| 4 |
Danaher
DHR
|
$68.9M |
| 5 |
Humana
HUM
|
$68M |
Sector Composition
| 1 | Healthcare | 98.39% |
| 2 | Industrials | 0.69% |
| 3 | Energy | 0.03% |
| 4 | Technology | 0.01% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Danaher
DHR
$143B
| $105M | 1.22% |
402,766
-264,784
| -40% | -$68.9M |
|
27
Inspire Medical Systems
INSP
$2.53B
| $102M | 1.18% |
397,506
-23,274
| -6% | -$5.97M |
|
|
SAGE
28
DELISTED
Sage Therapeutics
SAGE
| $101M | 1.17% |
3,052,404
-175,600
| -5% | -$5.81M |
|
29
Molina Healthcare
MOH
$9.6B
| $101M | 1.17% |
302,797
-11,785
| -4% | -$3.93M |
|
|
AMED
30
DELISTED
Amedisys
AMED
| $99.3M | 1.15% |
576,131
+86,119
| +18% | +$14.8M |
|
31
Option Care Health
OPCH
$4.7B
| $92.3M | 1.07% |
3,232,787
+308,744
| +11% | +$8.82M |
|
|
32
Outset Medical
OM
$245M
| $91.6M | 1.06% |
134,477
+97,103
| +260% | +$66.1M |
|
33
Sarepta Therapeutics
SRPT
$1.98B
| $89.9M | 1.04% |
1,151,159
+324,418
| +39% | +$25.3M |
|
|
34
CareDx
CDNA
$678M
| $85.5M | 0.99% |
2,311,176
+844,624
| +58% | +$31.2M |
|
35
Revolution Medicines
RVMD
$7.43B
| $84.5M | 0.98% |
3,310,662
-159,500
| -5% | -$4.07M |
|
36
Evolent Health
EVH
$1.11B
| $84.4M | 0.98% |
2,612,263
+2,970
| +0.1% | +$95.9K |
|
37
Insmed
INSM
$30.3B
| $83.5M | 0.97% |
3,551,776
+30,915
| +0.9% | +$727K |
|
|
SWAV
38
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $82.6M | 0.96% |
398,577
-28,033
| -7% | -$5.81M |
|
|
MYOV
39
DELISTED
Myovant Sciences Ltd.
MYOV
| $78M | 0.91% |
5,859,039
-310,000
| -5% | -$4.13M |
|
40
Kezar Life Sciences
KZR
$28.5M
| $77.6M | 0.9% |
466,815
-25,000
| -5% | -$4.16M |
|
41
HCA Healthcare
HCA
$95.4B
| $75.2M | 0.87% |
300,197
+5,763
| +2% | +$1.44M |
|
|
RDUS
42
DELISTED
Radius Health, Inc.
RDUS
| $73.5M | 0.85% |
8,318,714
+550,000
| +7% | +$4.86M |
|
43
Medtronic
MDT
$118B
| $72.8M | 0.85% |
656,030
-11,378
| -2% | -$1.26M |
|
44
MacroGenics
MGNX
$121M
| $64.5M | 0.75% |
7,325,514
-1,234,948
| -14% | -$10.9M |
|
45
Idexx Laboratories
IDXX
$50.7B
| $64.4M | 0.75% |
117,810
-169
| -0.1% | -$92.5K |
|
|
46
Humana
HUM
$37.5B
| $64.2M | 0.75% |
147,442
-156,255
| -51% | -$68M |
|
47
Regeneron Pharmaceuticals
REGN
$59.8B
| $63.1M | 0.73% |
90,280
-2,780
| -3% | -$1.94M |
|
48
Cigna
CI
$80.2B
| $62.1M | 0.72% |
259,146
+13,972
| +6% | +$3.35M |
|
49
Exelixis
EXEL
$9.95B
| $61.6M | 0.72% |
2,719,000
-140,000
| -5% | -$3.17M |
|
50
Align Technology
ALGN
$9.59B
| $61.6M | 0.72% |
141,351
-5,213
| -4% | -$2.27M |
|